Home
Arcus Biosciences

Arcus Biosciences Market Share Analysis for August 2026

Explore the role of adenosine in cancer immunotherapy and how Arcus Biosciences is targeting the adenosine axis to fight tumors.

Health > Biotechnology and Pharmaceuticals

Domainarcusbio.com

Year Founded2015

Employees501 - 1000

Annual Revenue$200M - $500M

Arcus Biosciences

Arcus Biosciences (including company regionals)

arcusbio.com

See more website traffic and engagement information

Arcus Biosciences Revenue up to August 2026 is 200M - 500M

revenue generated by Arcus Biosciences top domains

Arcus Biosciences top domains revenue over 3 years

Revenue for Arcus Biosciences top domains

arcusbio.com200M - 500M

See more with Sales Intelligence

Total visits to Arcus Biosciences's top domains

Understand Arcus Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

arcusbio.com8.2K

See more with Sales Intelligence

Avg. visit duration in Arcus Biosciences's top domains

Analyze Arcus Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

arcusbio.com00:01:06

See more with Sales Intelligence

Avg. pageviews on Arcus Biosciences's top domains

See how Arcus Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

arcusbio.com1.61

See more with Sales Intelligence

Arcus Biosciences top competitors by domain

Top similar sites in August 2026, ranked by their affinity

precisionbiosciences.comCompany NamePrecision BioSciencesEmployees51 - 200HQUnited States, North Carolina, DurhamAnnual revenue$100M - $200MTotal visits4.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Arcus Biosciences

These are the website technologies, by industry, used by Arcus Biosciences top domains

Advertising (8)

DoubleClick

Content Management System (4)

WordPress

Social (4)

Instagram

Widget (4)

Twemoji

More Technologies

9

See all

News & Signals from Arcus Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsArcus Biosciences, Inc. partnered with Summit Therapeutics Inc. on Jul 22nd '26.The collaboration between Arcus Biosciences, Inc. and Summit Therapeutics Inc. was announced on July 22.

NewsArcus Biosciences, Inc. is developing two-drug kidney cancer combination on Jun 3rd '26.Bristol-Myers Squibb (BMY) joins Arcus Biosciences to test a new two-drug kidney cancer combination.

NewsArcus Biosciences, Inc. partnered with Bristol-Myers Squibb Co on Jun 3rd '26.HAYWARD, Calif.-(BUSINESS WIRE)- Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases, today announced a clinical trial collaboration and supply agreement with Bristol Myers Squibb (NYSE: BMY, "BMS").